Perinatal mortality in Rh alloimmunized patients
- PMID: 16854514
- DOI: 10.1016/j.ejogrb.2006.06.007
Perinatal mortality in Rh alloimmunized patients
Abstract
Objective: Evaluate and compare the perinatal mortality of Rh-negative pregnancies managed at São Paulo Federal University during a 9-year period, using either amniocentesis or middle cerebral artery peak systolic velocity.
Method: Descriptive observational study involving 291 consecutive Rh-negative pregnancies managed between January 1995 and January 2004. The perinatal mortality of 99 alloimmunized patients was compared with 192 Rh-negative unimmunized patients (control group). The perinatal mortality of patients managed with amniocenteses was compared to those managed with Doppler studies.
Results: There were 74 patients managed with amniocenteses and 25 managed with Doppler studies. Perinatal mortality was significantly higher in the 99 Rh-negative isoimmunized patients than in the 192 unimmunized patients (12.1% versus 1%, p=0.0001) and did not differ according to the management protocol used (amniocentesis 13.5% versus cerebral Doppler 8.0%, p=0.725). Mean gestational age and mean weight at birth in pregnancies managed with amniocenteses (35.7 weeks and 2586 g) did not differ significantly from those managed with Doppler (36.3 weeks and 2647 g).
Conclusions: Perinatal mortality in Rh-negative alloimmunized patients remains high and does not differ whether pregnancies are managed through amniocentesis or cerebral Doppler evaluation.
Similar articles
-
A retrospective review of isoimmunized pregnancies managed by middle cerebral artery peak systolic velocity.Am J Obstet Gynecol. 2004 Jun;190(6):1732-6; discussion 1736-8. doi: 10.1016/j.ajog.2004.02.060. Am J Obstet Gynecol. 2004. PMID: 15284784
-
Management of red cell alloimmunized pregnancies using conventional methods compared with that of middle cerebral artery peak systolic velocity.Acta Obstet Gynecol Scand. 2009;88(4):475-8. doi: 10.1080/00016340902763228. Acta Obstet Gynecol Scand. 2009. PMID: 19235563
-
Non-invasive diagnosis of fetal anemia due to maternal red-cell alloimmunization.Saudi Med J. 2005 Feb;26(2):256-9. Saudi Med J. 2005. PMID: 15770301
-
Management of rhesus alloimmunization in pregnancy.Obstet Gynecol. 2002 Sep;100(3):600-11. doi: 10.1016/s0029-7844(02)02180-4. Obstet Gynecol. 2002. PMID: 12220785 Review.
-
Prevention and management of RhD isoimmunization.Clin Perinatol. 2004 Dec;31(4):721-42, vi. doi: 10.1016/j.clp.2004.06.005. Clin Perinatol. 2004. PMID: 15519425 Review.
Cited by
-
Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review.BMC Pregnancy Childbirth. 2024 Dec 20;24(1):830. doi: 10.1186/s12884-024-07044-3. BMC Pregnancy Childbirth. 2024. PMID: 39707247 Free PMC article.
-
Diagnosis of severe fetal anemia based on perinatal outcomes: a comparative analysis of the current reference values.Anemia. 2013;2013:351258. doi: 10.1155/2013/351258. Epub 2013 Nov 20. Anemia. 2013. PMID: 24349768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical